Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST–segment elevation myocardial infarction: Appropriate interpretation of the guidelines

This publication has 11 references indexed in Scilit:

• Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation
  Circulation, 2003
• ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article
  Journal of the American College of Cardiology, 2002
• 'I can see clearly now': a new view on the use of IV GP IIb/IIIa inhibitors in acute coronary syndromes.
  Published by Oxford University Press (OUP) ,2002
• Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy
  European Heart Journal, 2002
• CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
  Nature Medicine, 2002
• Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials
  The Lancet, 2002
• Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non–ST-Elevation Acute Coronary Syndromes
  Circulation, 1999
• Platelet GPIIb-IIIa blockers
  The Lancet, 1999
• Invasive versus conservative strategies in unstable angina and non\NQ-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 trial
  The American Journal of Cardiology, 1998
• CD40 signaling in vascular cells: A key role in atherosclerosis?
  Atherosclerosis, 1998